Radar · Life Sciences in San Carlos
Best Life Sciences Companies in San Carlos, United States
The 72 best Life Sciences companies in San Carlos, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Atreca.
By Riya SenguptaFinancials
72companies tracked
$2.2Bdisclosed funding
0unicorns
50have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × SAN CARLOS
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year
237kcombined LinkedIn audience
59%of audience held by top 3
3companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in San Carlos
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Atreca Developer of antibody therapeutics for human anti-cancer immune responses | $224M | 93 mo ago | Public | — | 2010 | — | 121 patents Patents concentrated in chemistry & materials | — |
| 2 | ZAP-X Developer of gyroscopic radiosurgery platform | $160M | 19 mo ago | Series E | — | 2014 | WordPressMySQLPHP+28 | 18 patents Patents concentrated in electrical & electronics | 1 award |
| 3 | Apexigen Specialty company that develops anti-body therapeutics for the treatment of cancer | $158M | 40 mo ago | Acqui-Hired | — | 2010 | — | 141 patents Patents concentrated in chemistry & materials | — |
| 4 | Dren Bio Developer of therapeutic antibodies for the treatment of cancer, autoimmune, and other serious diseases | $156M | 50 mo ago | Series B | — | 2019 | Apple iCloud MailMicrosoft 365Bootstrap+14 | — | — |
| 5 | Iovance Developer of T-cell therapies for the treatment of cancer | $155M | 120 mo ago | Public | Robert Brooke Founder & CEO | 2007 | DrupalApple iCloud MailPHP+22 | — | 1 launch |
| 6 | Noah Medical Developer of a robotic system designed for bronchoscopy procedures | $150M | 38 mo ago | Series B | Jian Zhang Founder & CEO | 2018 | HubSpot CMS HubApple iCloud MailMicrosoft 365+19 | 137 patents Robotic endoscopic navigation, instrumentation, and suturing for minimally invasive surgery | 1 launch · 2 awards |
| 7 | Galvanize Developer of pulsed electric field systems for various medical indications | $110M | 11 mo ago | Series C | Jonathan Waldstreicher Founder & CEO | 2020 | WordPressApple iCloud MailMicrosoft 365+21 | — | — |
| 8 | BigHat Provider of antibody therapies developed by machine learning and synthetic biology | $100M | 47 mo ago | Series B | Peyton Greenside Co-Founder & CSO | 2019 | WebflowApple iCloud MailGoogle Workspace+16 | — | — |
| 9 | NeurogesX Novel pain management therapies | $78M | 163 mo ago | Series D | — | 1998 | — | 96 patents Patents concentrated in health & consumer products | — |
| 10 | EpiBiologics Developer of antibody-based targeted therapies to treat multiple diseases 45Funding top 21%Talent top 38%Moat top 39%Innovation top 42% All 7 signals ▾Fundingtop 21% Talenttop 38% Moattop 39% Innovationtop 42% Patentstop 42% Globalbottom 37% Marketbottom 34% Funding: Raised $73.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $73M | 5 mo ago | Series B | Josef Gramespacher Co-Founder | 2021 | — | 13 patents Patents concentrated in chemistry & materials | 1 job opening |
| 11 | Flexus Biosciences Small-molecule cancer immunotherapies (IDO/TDO inhibitors) that target regulatory T cells. | $66M | 135 mo ago | Acquired | — | 2013 | — | 92 patents Patents concentrated in chemistry & materials | — |
| 12 | Link Cell Therapies Developer of CAR-T cell therapies for the treatment of cancer 11Funding top 29%Tech bottom 41%Global bottom 29%Market bottom 19% All 4 signals ▾Fundingtop 29% Techbottom 41% Globalbottom 29% Marketbottom 19% Funding: Raised $60.0M across 1 rounds · 1 rounds over 4 yrs (0.2/yr) Tech: 19 technologies across 3/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 11/100 | $60M | 6 mo ago | Series A | — | 2022 | WordPress Block EditorWordPressMySQL+16 | — | — |
| 13 | POINT Biomedical Domain name pointbio.com is for sale via Sedo Domain Parking | $56M | 221 mo ago | Deadpooled | Tom Feldman CEO | 1996 | — | 31 patents Ultrasound contrast agents and drug‑delivery micro/nanoparticles for medical imaging. | — |
| 14 | Cellerant Therapeutics for the regulation of hematopoietic ststem | $51M | 88 mo ago | Series C | — | 2003 | — | — | — |
| 15 | Arda Therapeutics Developer of therapeutics to remove pathological cells which are the root causes of chronic diseases | $43M | 20 mo ago | Series A | Adam Freund Founder & CEO | 2021 | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | — |
| 16 | Alkahest Plasma-based therapies leveraging AI for personalized medicine and disease solutions | $41M | 135 mo ago | Acquired | — | 2014 | WordPressMySQLPHP+16 | 403 patents Patents concentrated in health & consumer products | — |
| 17 | nugen technologies NuGEN Technology is a provider of genomics sample preparation solutions enabling scientists to access true… | $39M | 140 mo ago | Acquired | — | 2000 | — | 185 patents Patents concentrated in chemistry & materials | — |
| 18 | Isolation Bio Developer of a device for microbial isolation and cultivation | $39M | 66 mo ago | Series B | Michael Seely Co-Founder | 2014 | — | — | — |
| 19 | BioCardia Clinical-stage cardio regenerative medicine company with an initial focus on heart failure. | $37M | 89 mo ago | Public | Peter Altman CEO | 2002 | MySQLPHPLaravel+11 | 132 patents Minimally invasive cardiac delivery catheters and exosome‑based regenerative therapy platforms. | — |
| 20 | MyOme Provider of a platform for gene analysis to determine genetic diseases and drug response | $36M | 48 mo ago | Series B | Akash Kumar Co-Founder & Chief Medical & Scientific Officer | 2017 | Apple iCloud MailGoogle WorkspaceNode.js+19 | 33 patents Patents concentrated in computing, sensing & instrumentation | 1 job opening · 1 launch |
| 21 | Elegen Developer of a platform for the synthesis of DNA using microfluidic technology | $35M | 25 mo ago | Series B | Matt Hill Founder & CEO | 2017 | WordPressApple iCloud MailGoogle Workspace+24 | 26 patents Patents concentrated in computing, sensing & instrumentation | 3 launchs |
| 22 | Onc.ai AI-based cancer treatment and diagnosis platform for healthcare providers | $31M | 21 mo ago | Series A | Salmaan Ahmed VP Software | 2020 | WordPressMySQLPHP+20 | — | — |
| 23 | FerroKin BioSciences Graphic novel publisher offering diverse series, characters, and expanded knowledge | $30M | 172 mo ago | Acquired | — | 2007 | — | 57 patents Patents concentrated in chemistry & materials | — |
| 24 | Galaxy Medical Developer of a medical device to treat patients suffering from cardiac arrhythmia | $26M | 56 mo ago | Series A | — | 2020 | — | — | — |
| 25 | LimiFlex Developer of spinal implants for treating spinal stenosis | $25M | 33 mo ago | Series C | Louie Fielding COO and Co-Founder | 2008 | — | — | 1 launch |
| 26 | Spring Provider of AI-powered technology and tools for scientists | $22M | 90 mo ago | Series A | Ben Kamens Founder / CEO | 2017 | Framer SitesReactAmazon Web Services+13 | 15 patents Induction heating surfaces and heat lamp technologies for residential/commercial heating appliances. | — |
| 27 | BioTrace Medical Developer of cardiac pacing device to treat reversible symptomatic bradycardia | $22M | 63 mo ago | Series B | — | 2013 | — | — | — |
| 28 | TwoStep Therapeutics Developer of targeted cancer therapies focusing on solid tumors | $21M | 5 mo ago | Series A | Jennifer Cochran Co-Founder | 2024 | WordPressMySQLPHP+12 | — | — |
| 29 | Character Biosciences Developer of therapeutics for the treatment of age-related eye diseases | $18M | 9 mo ago | Series B | Marcel Brug Co-Founder | 2019 | — | — | — |
| 30 | CAGE Bio Developer of novel products based on ionic liquid platform for dermatology, inflammation, and immunology | $18M | 55 mo ago | Series A | Samir Mitragotri Co-Founder | 2016 | — | — | — |
| 31 | Prescient Surgical Situs Toto Togel Besar Resmi dan Terpercaya Hari Ini | $18M | 54 mo ago | Series B | — | 2012 | — | 21 patents Patents concentrated in health & consumer products | — |
| 32 | Omniox Biotherapeutics firm developing oxygen delivery vehicles for hypoxic tissue treatment | $15M | 93 mo ago | Series B | Stephen Cary Founder | 2006 | — | 65 patents Patents concentrated in health & consumer products | — |
| 33 | MEDiC Developer of CRISPR based cancer organoids for clinical trial tests | $13M | 20 mo ago | Seed | Hong-pyo Lee Co-Founder & CTO | 2019 | — | — | — |
| 34 | ReaMetrix In Vitro diagnostics platform | $11M | 199 mo ago | Deadpooled | Bala S Manian Founder & CEO | 2003 | — | 47 patents Optical biosensing and porous planar cell capture for viable microorganism detection | — |
| 35 | signature therapeutics, inc. Signature Therapeutics is focused on creating novel medicines to improve upon the therapeutic utility of… | $10M | 173 mo ago | Acqui-Hired | — | 2003 | — | — | — |
| 36 | Eiger BioPharmaceuticals Developer of antiviral agents against targets in the treatment of hepatitis | $9M | 85 mo ago | Public | — | 2000 | — | 181 patents Peptide therapeutics for metabolic disorders and antiviral treatments, especially exendin derivatives. | — |
| 37 | LiveLeaf Natural plant immunity for digestive health and fast relief | $9M | 133 mo ago | Series A | — | 2008 | — | 106 patents Patents concentrated in health & consumer products | — |
| 38 | Phinomics Developer of a genome-based technology to detect cancer | $4M | 14 mo ago | Funding Raised | Stephen Levene Co-Founder | 2021 | — | — | — |
| 39 | Logomix Provider of genome engineering platform to create artificial cells | $4M | 10 mo ago | Series A | Taiki Ishikura Co-Founder & CEO | 2019 | — | 4 patents Patents concentrated in computing, sensing & instrumentation | — |
| 40 | SiftBio Developer of peptide immunotherapies for cancer and autoimmune diseases | $4M | 6 mo ago | Seed | Maddie Williams Co-Founder & CTO | 2024 | — | — | — |
| 41 | IHP Therapeutics Developer of a self-administered treatment for sickle cell disease vaso-occlusive crisis | $4M | 9 mo ago | Funding Raised | Robert Van Gorp Co-Founder | 2020 | — | — | — |
| 42 | Signature Therapeutics Develops prodrug formulations that can prevent the misuse of prescription medications | $2M | 47 mo ago | Acquired | Steven Shafer Co-Founder | 2004 | WordPress Block EditorWordPressMySQL+21 | — | — |
| 43 | Ciel Medical Devices Ventilator-associated pneumonia prevention devices | $2M | 115 mo ago | Acqui-Hired | — | 2012 | — | — | — |
| 44 | Vcreate Developer of T-cell receptor based therapies for the treatment of cancer | $2M | 13 mo ago | Funding Raised | Binbin Chen Co-Founder & CEO | 2021 | — | 7 patents Patents concentrated in chemistry & materials | — |
| 45 | Isla technologies Developer of minimally invasive cell implant to treat type 1 diabetes | $1M | 39 mo ago | Seed | Sara Photiadis CEO | 2020 | — | — | — |
| 46 | Protein Metrics Provider of software solutions for protein characterization | $950K | 62 mo ago | Series A | Yong Kil VP of Development and Co-Founder | 2011 | — | 55 patents Patents concentrated in electrical & electronics | — |
| 47 | Aperture Therapeutics Provider of bioinformatics solutions for genetic drug discovery | $915K | 11 mo ago | Funding Raised | Martin Jacko CEO | 2022 | — | — | — |
| 48 | Rattan Life Science Developer of iPSC-derived T cells for cancer and immune disorder treatment | $275K | 36 mo ago | Funding Raised | Hui Gai Founder | 2022 | — | — | — |
| 49 | Dorian Therapeutics Developer of therapies for aging diseases | $150K | 13 mo ago | Acquired | — | 2018 | — | — | — |
| 50 | Epinoma Limited information available | $125K | 56 mo ago | Seed | — | 2020 | — | — | — |
Top 12 Life Sciences companies in San Carlos
#1
Series B · San Carlos, California · founded 2021 · 22 employees$73Mraised▾
Series B · San Carlos, California · founded 2021 · 22 employees
Developer of antibody-based targeted therapies to treat multiple diseases. The company has a proprietary EpiTAC platform that enables the development of first-in-class and best-in-class targeted therapies that degrade disease-driving membrane and extracellular proteins against a wide range of disorders.
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 21%Talent
top 38%Moat
top 39%Innovation
top 42%Patents
top 42%Global
bottom 37%Funding: Raised $73.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Jan 2026)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 4/10 · IP moat: 13 patents · Soonicorn
Audience (LinkedIn): 5k LinkedIn followers — 2.2% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Mass Spec Scientist Large Molecule Characterization
Funding rounds
- Jan 2026Series B$107M
- Jul 2023Series A$23M
- Mar 2023Series A$50M
Founders & team
Investors
Mubadala, Polaris Partners, Vivo Capital, Google Ventures, Digitalis Ventures, Taiho Ventures
#2
Series A · San Carlos, California · founded 2022 · 8 employees$60Mraised▾
Series A · San Carlos, California · founded 2022 · 8 employees
Developer of CAR-T cell therapies for the treatment of cancer
Fliar Intelligence Index™ 11how this company ranks against its industry peers
Funding
top 29%Tech
bottom 41%Global
bottom 29%Market
bottom 19%Funding: Raised $60.0M across 1 rounds · 1 rounds over 4 yrs (0.2/yr) · Last round Series A (Dec 2025)
Tech: 19 technologies across 3/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Http/3
Global: Single-market focus (United States)
Audience (LinkedIn): 6k LinkedIn followers — 2.5% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. Jonathan & Johnson) announced in 12 mo
Funding rounds
- Dec 2025Series A$60M
- 2022Seed—
Investors
Johnson & Johnson Innovation, Samsara BioCapital, Wing Venture Capital, Sheatree Capital
#3
Series C · San Carlos, California · founded 2020 · 114 employees$110.1Mraised▾
Series C · San Carlos, California · founded 2020 · 114 employees
Developer of pulsed electric field systems for various medical indications. The company is developing and commercializing its energy platform for several indications, which include the RheOx system a minimally invasive bronchoscopic therapy for chronic bronchitis, The CENTAURI system for cardiac arrhythmias, and the Aliya system for immuno-oncology and soft tissue ablation.
Funding rounds
- Jul 2025Series C$100M
- Sep 2022Series B$100M
- Mar 2022Series A$4M
- Oct 2020Series A$6.1M
Founders & team
Investors
Fidelity Investments, Apple Tree Partners, Intuitive, Gilmartin Capital, Sofinnova Partners, Elevage Medical Technologies
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCore-JsDocusignDraftpress Hfcm
#4
Series A · San Carlos, California · founded 2024$21.1Mraised▾
Series A · San Carlos, California · founded 2024
Developer of targeted cancer therapies focusing on solid tumors. The company uses a multi-targeting platform based on a Polyspecific Integrin-binding Peptide to create targeted cancer therapies for drug delivery and radioligand therapy.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
- Jan 2026Series A$21.1M
- Jun 2024Seed—
Founders & team
Investors
2048 Ventures, NFX, Alexandria Venture Investments
Tech stack
BootstrapCdnjsCloudflareFont AwesomeGodaddyJquery
#5
Series B · San Carlos, California · founded 2019 · 30 employees$18Mraised▾
Series B · San Carlos, California · founded 2019 · 30 employees
Developer of therapeutics for the treatment of age-related eye diseases. The company’s integrated platform includes machine learning, computational biology, drug discovery, and diagnostic development to develop treatments for age-related progressive diseases. The company has drugs for Age-related macular degeneration (AMD) and Glaucoma.
Funding rounds
- Sep 2025Series B$8.9M
- Mar 2025Series B$93M
- May 2022Series A$18M
Founders & team
Investors
Innovation Endeavors, Catalio Capital Management, Lifeforce Capital, Casdin Capital, Clover Health, Industry Ventures
#6
Series E · San Carlos, California · founded 2014 · 115 employees$160Mraised▾
Series E · San Carlos, California · founded 2014 · 115 employees
Developer of gyroscopic radiosurgery platform. The company's flagship product, ZAP-X platform is a self-shielding technology and non-invasive cancer radiotherapy treatment device. It has applications for the treatment of brain and head and neck cancers.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 21k LinkedIn followers — 8.8% of this cohort's audience · 54 engagements/post (1.7× cohort median)
Activity: 1 awards announced in 12 mo
Funding rounds
- Nov 2024Series E$78M
- Jan 2020Series D$81M
Investors
Primavera, GT Healthcare Capital Partners, Chow Tai Fook Jewellery, ShangBay Capital, Hogy Medical, Varian Medical Systems
Tech stack
CloudflareCloudflare Bot ManagementCookieyesCore-JsElementorEnhanced Responsive Images
#7
Seed · San Carlos, California · founded 2024$3.8Mraised▾
Seed · San Carlos, California · founded 2024
Developer of peptide immunotherapies for cancer and autoimmune diseases. The company uses a proprietary peptide immunotherapy platform that combines AI, metagenomics, and high‑throughput T‑cell screening to discover peptides that massively amplify immune responses. The goal is to create targeted, effective, and safer treatments for cancers and autoimmune conditions.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Funding rounds
- Nov 2025Seed$3.8M
Founders & team
Investors
LifeSpan Vision Ventures, FreeFlow, Valuence Ventures, Eisai Innovation, SBI US Gateway Fund
#8
Funding Raised · San Carlos, California · founded 2020$3.6Mraised▾
Funding Raised · San Carlos, California · founded 2020
Developer of a self-administered treatment for sickle cell disease vaso-occlusive crisis. This treatment aims to provide a novel approach to managing acute pain crises by blocking key mechanisms of vaso-occlusion. The therapy is designed for home administration, potentially reducing reliance on healthcare facilities. It offers a potential disease-modifying effect, aiming to lessen both pain and organ damage associated with the condition.
Funding rounds
- Aug 2025Grant (prize money)$982.1K
- Mar 2023Grant (prize money)$2.6M
Founders & team
Investors
HHS
#9
Series A · San Carlos, California · founded 2021 · 5 employees$43.3Mraised▾
Series A · San Carlos, California · founded 2021 · 5 employees
Developer of therapeutics to remove pathological cells which are the root causes of chronic diseases. The company uses single-cell data to identify pathological cells to target and design therapies for eliminating the pathological cells that drive chronic diseases and aging.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 2.4% of this cohort's audience
Hiring: 2 hiring posts in 12 mo (public) · hiring: Scientist/Senior Scientist, Protein Sciences
Activity: 1 partnerships (incl. Cellazon) announced in 12 mo
Funding rounds
- Oct 2024Series A$43.3M
Founders & team
Investors
Andreessen Horowitz, Two Sigma Ventures, RV Invest, Biovision Ventures, Lilly, Valhalla Ventures
Tech stack
AngularCart FunctionalityCore-JsGoogle WorkspaceHstsModernizr
#10
Series A · San Carlos, California · founded 2019 · 18 employees$3.8Mraised▾
Series A · San Carlos, California · founded 2019 · 18 employees
Provider of genome engineering platform to create artificial cells. The company has Geno-Writing, a large-scale genome construction technology that allows genome modification and synthesizing cellular genomes of various species other than humans. The company's pipeline includes cellular systems of various species such as bacteria, yeast, cultured animal cells, and human stem cells.
Funding rounds
- Jul 2025Series A$18.9M
- Feb 2023Seed$3.8M
Founders & team
Investors
Angel Bridge, Sand Hill Angels, JAFCO, UTokyo Innovation Platform, Globis Capital Partners, ITOCHU Technology Ventures
#11
Series A · San Carlos, California · founded 2020 · 32 employees$31Mraised▾
Series A · San Carlos, California · founded 2020 · 32 employees
AI-based cancer treatment and diagnosis platform for healthcare providers. The platform assists in the decision-making process for providing and aiding in cancer treatment decisions using AI technology, genomics, proteomics, radionics, and more.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
- Sep 2024Grant (prize money)$1.6M
- Jan 2023Series A$25M
- Dec 2020Series A$6M
Founders & team
Investors
MassMutual, Action Potential Venture Capital, Life Extension Ventures, BVF, Digitalis Ventures, KdT Ventures
Tech stack
BootstrapBrowser-Update.OrgCookieyesCore-JsDropzoneFont Awesome
#12
Seed · San Carlos, California · founded 2019 · 9 employees$13Mraised▾
Seed · San Carlos, California · founded 2019 · 9 employees
MEDIC life sciences has developed CRISPR based cancer organoids for clinical trial research. The genome-scale CRISPR/Cas9 functional genomics tool has been incorporated into 3D cancer organoids based on the required cancer type to recapitulate genetic mutations in the tumors.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Funding rounds
- Oct 2024Seed$5M
- 2023Seed$8M
Founders & team
Investors
Hanmi Pharmaceuticals, Lgchem, Illumina, Top Harvest Capital, Primer Sazze Partners, Big Basin Capital
Funding & investor landscape
$2.2Btotal disclosed funding
52companies funded
185disclosed rounds
0rounds last 90 days
Most active investors
Notable founders
Josef Gramespacher
Co-Founder · EpiBiologics
Ann Lee-Karlon
CEO · EpiBiologics
Jonathan Waldstreicher
Founder & CEO · Galvanize
Jennifer Cochran
Co-Founder · TwoStep Therapeutics
Ronald Levy
Co-Founder · TwoStep Therapeutics
Marcel Brug
Co-Founder · Character Biosciences
Maddie Williams
Co-Founder & CTO · SiftBio
Yue Lou
Co-Founder & CEO · SiftBio
Robert Van Gorp
Co-Founder · IHP Therapeutics
Rinko Ghosh
Co-founder & CEO · IHP Therapeutics
Adam Freund
Founder & CEO · Arda Therapeutics
Taiki Ishikura
Co-Founder & CEO · Logomix
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · United States
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
research sentiment over time
200820162026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and steady — the enthusiastic (strongly-positive) share moved 44% → 42% across 2008–2026.
top research entities
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
leading researchers
Stylianos Chatzimanolis · TARIK DEDOVIC · KATH-RYN ANN F. HANKINS · Christoforos Pavlou · Giannis Bolanakis · Ashley R Tetens · Tyler Findlay · Jordyn Craig-Schwartz
▲
Breakthroughs2,038 · 33%
▼ 41%→30% share
▼0.7× share momentum0 median citations71% since 2021mostly empirical
Breakthroughs are cooling (41%→30% of field), led by Gene.
rising sub-themes (early→recent)
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
Newly emergingIdentification (biology) 0→18 · Function (biology) 0→18 · Reporter gene 0→16
Landmark U1 snRNP regulates cancer cell migration and invasion in vitro · 7,224 cites
◆
Advancements2,118 · 34%
▲ 29%→35% share
▲1.2× share momentum0 median citations80% since 2021mostly empirical
Advancements are rising (29%→35% of field), led by Gene.
rising sub-themes (early→recent)
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
Newly emergingIdentification (biology) 0→27 · Probiotic 0→24 · Cultivar 0→23
Landmark Using Deep Learning for Image-Based Plant Disease Detection · 4,262 cites
▼
Concerns1,006 · 16%
▼ 17%→15% share
▼0.9× share momentum0 median citations73% since 2021mostly empirical
Concerns are cooling (17%→15% of field), led by Agriculture.
rising sub-themes (early→recent)
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Newly emergingQuality (philosophy) 0→27 · Animal health 0→14 · Integrated pest management 0→13
Landmark The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate · 8,812 cites
RESEARCH HOTSPOTS · United States
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Boston351 · +0.52
New York319 · +0.47
SF Bay Area235 · +0.57
Philadelphia115 · +0.60
San Diego101 · +0.59
Seattle95 · +0.46
Chicago95 · +0.57
Los Angeles93 · +0.61
Pittsburgh65 · +0.54
Ann Arbor65 · +0.58
PATENT SIGNAL · United States
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
457,918 filings8,000 assigneespeak 51616/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
How many Life Sciences companies are there in San Carlos, United States?
Radar tracks 72 indexable Life Sciences companies headquartered in San Carlos, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in San Carlos, United States?
The Life Sciences companies in San Carlos, United States on this list have raised a combined $2.2B in disclosed equity funding across 52 funded companies.
Which is the highest-funded Life Sciences company in San Carlos, United States?
Atreca is the highest-funded Life Sciences company in San Carlos, United States, with $224.4M in disclosed equity funding.
How many Life Sciences companies in San Carlos, United States are funded?
52 of the 72 Life Sciences companies in San Carlos, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in San Carlos, United States?
None of the Life Sciences companies in San Carlos, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in San Carlos, United States Life Sciences companies?
The most active investors in San Carlos, United States Life Sciences companies on this list include HHS, 8VC, AME Cloud Ventures, Andreessen Horowitz, Digitalis Ventures.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.